LGND
Ligand Pharmaceuticals margins
- Stocks
- Healthcare
- NASDAQ: LGND
- Margins
For this period, Ligand Pharmaceuticals reports a gross margin of 95.2%, an operating margin of 9.5%, an EBITDA margin of 38.8%, and a net margin of 20.3%. Operating margin reported the largest year-over-year gain at 2.3 percentage points, whereas EBITDA margin reported the largest decline at 2.2 percentage points.
LGND margin history
Ligand Pharmaceuticals's margins averaged 93.59% gross, 1.68% operating, 51.14% EBITDA, and 23.03% net over the last 3 years. The current figures show gross and operating margins are above their three-year averages, while EBITDA and net margins are below their three-year averages.
LGND margin expansion
Compared with the same period last year, gross margin expanded by 0.9 percentage points, operating margin by 2.3 percentage points, and net margin by 1 percentage point, while EBITDA margin contracted by 2.2 percentage points.
LGND Gross margin
Over the last 3 years, the average gross margin for Ligand Pharmaceuticals was 93.59%. The latest gross margin for Ligand Pharmaceuticals is 95.2%, 1.6 percentage points above its three-year average. Ligand Pharmaceuticals's gross margin ranged from a low of 91.8% in Mar 2024 to a high of 95.4% in Jun 2026.
LGND Operating margin
Looking back over the last 3 years, Ligand Pharmaceuticals recorded an average operating margin of 1.68%. Compared with its three-year average, Ligand Pharmaceuticals's current operating margin is 9.5% and is 7.8 percentage points above its three-year average. The highest operating margin for Ligand Pharmaceuticals was 34.6% in Mar 2026, while the lowest was -34.1% in Mar 2025.
LGND EBITDA margin
The average EBITDA margin for Ligand Pharmaceuticals was 51.14% during the last 3 years. At present, the current EBITDA margin for Ligand Pharmaceuticals is 38.8%, 12.3 percentage points below its three-year average. The EBITDA margin for Ligand Pharmaceuticals moved between -66.1% in Mar 2025 and 135% in Mar 2024.
LGND Net margin
Throughout the last 3 years, Ligand Pharmaceuticals had an average net margin of 23.03%. Against its three-year average, Ligand Pharmaceuticals's net margin is currently 20.3%, 2.7 percentage points below its three-year average. Looking back over the last 3 years, Ligand Pharmaceuticals's net margin reached 81.4% at its highest point in Mar 2024 and -73.1% at its lowest in Mar 2025.
LGND margin group comparison
With a gross margin of 95.2%, LGND ranks higher than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 68.4%, Ligand Pharmaceuticals's gross margin is 39% higher.
LGND margin peer comparison
Frequently asked questions
What is Ligand Pharmaceuticals's gross margin?
The current gross margin for LGND is 95.2% as of Sep 30, 2026.
What is Ligand Pharmaceuticals's operating margin?
The current operating margin for LGND is 9.5% as of Sep 30, 2026.
What is Ligand Pharmaceuticals's EBITDA margin?
For the period ending Sep 30, 2026, LGND recorded an EBITDA margin of 38.8%.
What is Ligand Pharmaceuticals's net margin?
For the period ending Sep 30, 2026, LGND recorded a net margin of 20.3%.
What are the average margins of LGND?
Over the past 3 years, LGND reported average margins of 93.6% gross, 1.7% operating, 51.1% EBITDA, and 23.0% net.
What are the highest historical margins of LGND?
Looking back across 5 years, LGND reached 95.4% gross in Jun 2026, 45.4% operating in Mar 2022, 135% EBITDA in Mar 2024, and 81.4% net in Mar 2024.
What are the lowest historical margins of LGND?
Over the last 5 years, Ligand Pharmaceuticals's lowest margins were 73.1% gross in Dec 2022, -34.1% operating in Mar 2025, -66.1% EBITDA in Mar 2025, and -73.1% net in Mar 2025.